Axa
TARO

Axa’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Axa’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,900
Closed -$497K – 1342
2021
Q2 		$497K Buy
6,900
+2,600
+60% +$191K ﹤0.01% 1106
2021
Q1 		$317K Sell
4,300
-11,900
-73% -$904K ﹤0.01% 1130
2020
Q4 		$1.19M Hold
16,200
– – ﹤0.01% 944
2020
Q3 		$889K Sell
16,200
-18,100
-53% -$1.13M ﹤0.01% 959
2020
Q2 		$2.28M Buy
34,300
+14,500
+73% +$972K 0.01% 797
2020
Q1 		$1.21M Buy
+19,800
New +$1.47M 0.01% 823
2019
Q4 		– Sell
-8,843
Closed -$667K – 1349
2019
Q3 		$667K Buy
+8,843
New +$718K ﹤0.01% 1053

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Axa's TARO Position: Q3 2021 in Review

Axa sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2021, closing a stake of 6,900 shares — an estimated $497K sold.

Axa first reported a position in TARO in Q3 2019 and held it in 7 quarters. The position peaked at $2.28M in Q2 2020. 71 funds tracked by Wall St. Rank hold TARO as of Q3 2021.

  • Axa reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2021 after selling out during the quarter.
  • Axa sold 6,900 Taro Pharmaceutical Industries Ltd. shares in Q3 2021, an estimated $497K.
  • Axa first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2019 and held it in 7 quarters.
  • Axa's Taro Pharmaceutical Industries Ltd. position peaked at $2.28M in Q2 2020.
  • 71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2021.

Based on Axa's 13F filing for Q3 2021, filed 15 Nov 2021.